close
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 17;364(6441):636-637.
doi: 10.1126/science.aaw1299.

Senolytic therapies for healthy longevity

Affiliations

Senolytic therapies for healthy longevity

Jan M van Deursen. Science. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

COI: J.M.v.D. is a cofounder of Unity Biotechnology and an inventor on patents licensed to or filed by Unity Biotechnology.

Figures

Figure.
Figure.. Senolytic therapies for optimized aging.
SNCs resist cell death by activating prosurvival and inhibiting pro-apoptotic pathways. First generation senolytic drugs developed to effectively target key components of these pathways eliminate SNCs and thereby the SASP that drives diseases of aging. Clinical testing of one such drug, UBX0101, is ongoing for the treatment of osteoarthritis, with a second drug, UBX1967, advancing to human testing for eye diseases. Development of highly selective senolytics that safely and effectively eliminate SNCs upon systemic administration for treatment of neurodegenerative or cardiovascular diseases, among others, awaits further advancements from fundamental and translational research on SNCs.

References

    1. Baker DJ et al. , Nature 479, 232–236 (2011). - PMC - PubMed
    1. Baker DJ et al. , Nature 530, 184–189 (2016). - PMC - PubMed
    1. van Deursen JM, Nature 509, 439–446 (2014). - PMC - PubMed
    1. Coppe JP et al. , PLoS Biol 6, 2853–2868 (2008). - PMC - PubMed
    1. Yosef R et al. , Nat Commun 7, 11190 (2016). - PMC - PubMed

Publication types